COTS Technology Co., Ltd. (KOSDAQ:448710)
18,410
-180 (-0.97%)
At close: Feb 6, 2026
COTS Technology Revenue
COTS Technology had revenue of 21.32B KRW in the quarter ending September 30, 2025, with 1.50% growth. This brings the company's revenue in the last twelve months to 70.65B, up 16.82% year-over-year. In the year 2024, COTS Technology had annual revenue of 64.98B with 26.67% growth.
Revenue (ttm)
70.65B
Revenue Growth
+16.82%
P/S Ratio
1.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
97.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.98B | 13.68B | 26.67% |
| Dec 31, 2023 | 51.30B | 9.46B | 22.62% |
| Dec 31, 2022 | 41.84B | 9.94B | 31.15% |
| Dec 31, 2021 | 31.90B | 7.16B | 28.94% |
| Dec 31, 2020 | 24.74B | 1.47B | 6.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NVH Korea | 1.64T |
| Dong-A Hwa Sung | 405.21B |
| Ahn-Gook Pharmaceutical | 300.96B |
| Inics | 123.55B |
| Sam-A Pharm. | 76.66B |
| Mr. Blue | 69.96B |
| Youil Energy Tech | 44.40B |
| NFC Corporation | 34.07B |